Hi Stockrock, if your referring to whom I suspect, I had already put him on ignore, I invite contrarian views but after reading his posts several times I still had no idea what he was saying.
But like you, I'm excited that we have a drug that may potentially provide an answer to a very serious problem. There will be ups and downs and possibly something from left field at some stage, but what a 12 - 18 months we have. Patience is its own reward.
If not for the patient with edema it would have been 100%. And if your in a hospital, edema can be quickly treated. Go figure.
Coincidentally I hold another ASX micro that is planning to run Phase 2 trials next year in England and Italy and I know from correspondence with the CEO that he is very keen to include Glioblastoma in the trials, so I may have 2 shots at it.
Please continue with your posts, I enjoy them thoroughly as I'm sure do others.
Pete
CHM Price at posting:
32.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)